Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate UpdateAccesswire • 08/11/21
Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration RegimenAccesswire • 08/11/21
Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021Accesswire • 08/03/21
Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette UseAccesswire • 07/22/21
Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of CytisiniclineAccesswire • 06/29/21
Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of AddictionAccesswire • 06/03/21
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesAccesswire • 05/27/21
Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public OfferingAccesswire • 05/25/21
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate UpdateAccesswire • 05/13/21
Achieve Life Sciences to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021Accesswire • 05/04/21
Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco ResearchAccesswire • 04/14/21
Achieve Announces Publication of the RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix(R) (varenicline) in AddictionAccesswire • 03/25/21
Achieve Life Sciences to Participate in M-Vest and Maxim Group Inaugural Emerging Growth Virtual ConferenceAccesswire • 03/16/21
Achieve Life Sciences Announces Appointment of Dr. Bridget Martell and Dr. Cindy Jacobs to Board of DirectorsAccesswire • 03/15/21
Achieve Life Sciences, Inc. (ACHV) CEO John Bencich on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/12/21
Achieve Reports Financial Results for Fourth Quarter and Year-End 2020 and Provides Corporate UpdateAccesswire • 03/11/21
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call and Webcast on March 11, 2021Accesswire • 03/04/21
Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect ConferenceAccesswire • 01/07/21
Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment OptionPRNewsWire • 12/07/20